Send mail to Author

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes : rationale and design of the ODYSSEY Outcomes trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___      _____      ___       _____     ___    
| |  | ||   / _ \\   |__  //    / _ \\    / ___//   / _ \\  
| |/\| ||  / //\ \\    / //    | / \ ||   \___ \\  / //\ \\ 
|  /\  || |  ___  ||  / //__   | \_/ ||   /    // |  ___  ||
|_// \_|| |_||  |_|| /_____||   \___//   /____//  |_||  |_||
`-`   `-` `-`   `-`  `-----`    `---`   `-----`   `-`   `-`
 


Back to frontdoor view

OPUS4 Logo